SCHEMBL4495832

SCHEMBL4495832

C[C@]1(CC(=O)O)CCc2cc(C#N)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.42
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
HSD11B1 P28845 1/20 0.38
EP300 Q09472 1/20 0.38
CREBBP Q92793 1/20 0.38
DGAT1 O75907 2/20 0.38
NAMPT P43490 1/20 0.37
DRD2 P14416 5/20 0.37
DRD3 P35462 5/20 0.37
PNMT P11086 1/20 0.37
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
SLC6A4 P31645 1/20 0.36
FFAR1 O14842 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
PTGER4 P35408 1/20 0.36
CXCR5 P32302 1/20 0.35
DRD4 P21917 1/20 0.35
OPRM1 P35372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4495829 1.00 KDM1A (0.42) KDM1AESR1ESR2HSD11B1EP300
SCHEMBL10341533 0.83 DGAT1 (0.55) HSD11B1DGAT1
SCHEMBL8008765 0.77 ESR1 (0.42) ESR1ESR2DGAT1MAPK1FFAR1
SCHEMBL3706515 0.75 DGAT1 (0.45) DGAT1LMNA
SCHEMBL10341501 0.75 DGAT1 (0.42) HSD11B1DGAT1NAMPTFFAR1FFAR4
SCHEMBL3411510 0.73 ESR1 (0.49) ESR1ESR2DGAT1LMNAOPRM1
SCHEMBL3749487 0.73 ESR1 (0.49) ESR1ESR2DGAT1LMNAOPRM1
SCHEMBL10341554 0.70 DGAT1 (0.45) DGAT1NAMPTDRD2DRD3DRD4
SCHEMBL10869205 0.70 DGAT1 (0.39) HSD11B1DGAT1
SCHEMBL8011044 0.69 DGAT1 (0.39) DGAT1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605171-B2 (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists MERCK & CO., INC. (US) 2009-10-20 US disclosed
US-20080249093-A1 (3,4-Disubstituted)Propanoic Carboxylates as Sip (Edg) Receptor Agonists MERCK & CO., INC. (US) 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249093-A1 (3,4-Disubstituted)Propanoic Carboxylates as Sip (Edg) Receptor Agonists S1PR1, S1PR3, S1PR5 KDM1A 1305/4885ESR1 752/4885ESR2 444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.